1. Home
  2. PFO vs LFCR Comparison

PFO vs LFCR Comparison

Compare PFO & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFO
  • LFCR
  • Stock Information
  • Founded
  • PFO 1991
  • LFCR 1986
  • Country
  • PFO United States
  • LFCR United States
  • Employees
  • PFO N/A
  • LFCR 406
  • Industry
  • PFO Finance Companies
  • LFCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFO Finance
  • LFCR Health Care
  • Exchange
  • PFO Nasdaq
  • LFCR Nasdaq
  • Market Cap
  • PFO 127.2M
  • LFCR 255.1M
  • IPO Year
  • PFO N/A
  • LFCR N/A
  • Fundamental
  • Price
  • PFO $9.62
  • LFCR $6.83
  • Analyst Decision
  • PFO
  • LFCR Buy
  • Analyst Count
  • PFO 0
  • LFCR 4
  • Target Price
  • PFO N/A
  • LFCR $8.00
  • AVG Volume (30 Days)
  • PFO 31.8K
  • LFCR 209.0K
  • Earning Date
  • PFO 01-01-0001
  • LFCR 10-03-2025
  • Dividend Yield
  • PFO 6.51%
  • LFCR N/A
  • EPS Growth
  • PFO N/A
  • LFCR N/A
  • EPS
  • PFO N/A
  • LFCR N/A
  • Revenue
  • PFO N/A
  • LFCR $128,867,000.00
  • Revenue This Year
  • PFO N/A
  • LFCR $4.72
  • Revenue Next Year
  • PFO N/A
  • LFCR $10.97
  • P/E Ratio
  • PFO N/A
  • LFCR N/A
  • Revenue Growth
  • PFO N/A
  • LFCR 0.47
  • 52 Week Low
  • PFO $6.90
  • LFCR $4.76
  • 52 Week High
  • PFO $8.51
  • LFCR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • PFO 44.63
  • LFCR 47.35
  • Support Level
  • PFO $9.61
  • LFCR $6.70
  • Resistance Level
  • PFO $9.77
  • LFCR $6.94
  • Average True Range (ATR)
  • PFO 0.13
  • LFCR 0.24
  • MACD
  • PFO -0.03
  • LFCR 0.04
  • Stochastic Oscillator
  • PFO 12.42
  • LFCR 82.79

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: